Is there a Difference in the Tolerability of Overactive Bladder Medications?

Staskin D1, Herschorn S2, Walsh T3, Bradt P3, Schermer C3, Schermer C3

Research Type

Clinical

Abstract Category

Overactive Bladder

Abstract 115
Open Discussion ePosters
Scientific Open Discussion Session 7
Wednesday 14th September 2016
12:25 - 12:30 (ePoster Station 5)
ePoster Area
Clinical Trial Pharmacology Questionnaire
1. Tufts University School of Medicine, 2. Sunnybrook Health Sciences Centre, 3. Astellas
Presenter
D

David Staskin

Links

Abstract

24/04/2024 02:03:20